Core Scientific (CORZ) EBIT (2020 - 2026)

Core Scientific (CORZ) has 7 years of EBIT data on file, last reported at -$310.4 million in Q1 2026.

• Quarterly EBIT fell 559.94% year-over-year to -$310.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$509.0 million (down 108.31% YoY) and the FY2025 annual result came in at -$245.6 million, down 72.87% from the prior year.
• EBIT declined to -$310.4 million in Q1 2026 per CORZ's latest filing, from -$117.5 million in the prior quarter.
• The five-year high for EBIT was $55.2 million in Q1 2024, with the low at -$1.0 billion in Q2 2022.
• Average EBIT over 5 years is -$164.6 million, with a median of -$47.0 million recorded in 2025.
• Year-over-year, EBIT plunged 8489.92% in 2022 and soared 626.48% in 2024.
• Core Scientific's EBIT stood at -$636.1 million in 2022, then jumped by 100.62% to $3.9 million in 2023, then slumped by 1762.2% to -$65.4 million in 2024, then plunged by 79.65% to -$117.5 million in 2025, then slumped by 164.25% to -$310.4 million in 2026.
• Business Quant data shows CORZ's EBIT at -$310.4 million in Q1 2026, -$117.5 million in Q4 2025, and -$54.8 million in Q3 2025.